US Stock MarketDetailed Quotes

DNTH Dianthus Therapeutics

Watchlist
  • 21.770
  • +0.320+1.49%
Trading Apr 29 12:36 ET
699.38MMarket Cap-8.54P/E (TTM)

About Dianthus Therapeutics Company

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.

Company Profile

SymbolDNTH
Company NameDianthus Therapeutics
Listing DateJun 21, 2018
Founded2015
CEOMr. Marino Garcia
MarketNASDAQ
Employees78
Fiscal Year Ends12-31
Address7 Times Square,43rd Floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10036
Phone1-929-999-4055
Websitehttp://dianthustx.com

Company Executives

  • Name
  • Position
  • Salary
  • Marino Garcia
  • President, Chief Executive Officer and Director
  • 8.84M
  • Ryan Savitz
  • Chief Financial Officer, Chief Business Officer and Treasurer
  • 4.00M
  • Edward G. Carr
  • Chief Accounting Officer
  • --
  • Dr. Simrat Randhawa, M.D.
  • Chief Medical Officer
  • 4.04M
  • Adam M. Veness
  • Senior Vice President, General Counsel and Secretary
  • --
  • Alison F. Lawton
  • Chairman of the Board
  • 252.91K
  • Sujay R. Kango
  • Director
  • --
  • Paula Soteropoulos
  • Independent Director
  • 239.91K
  • Anne M. McGeorge
  • Independent Director
  • 238.41K
  • Leon O. Moulder, Jr
  • Independent Director
  • 246.41K
  • Dr. Steven Joseph Romano, M.D.
  • Independent Director
  • 459.27K
  • Dr. Jonathan Violin, M.B.A.,PhD
  • Independent Director
  • 227.41K

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Super-Dragon Engineering Plastics
301131
+20.01%
Broadex Technologies
300548
+20.01%
Zhejiang Zhaofeng Mechanical And Electronic
300695
+20.01%
4
Jing-Jin Electric Technologies
688280
+20.00%
5
Hangzhou Anysoft Information Technology
300571
+20.00%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.